Trial Profile
An observational, pilot study to evaluate the tolerability and efficacy of mirabegron for the treatment of overactive bladder in multiple sclerosis patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Feb 2016
Price :
$35
*
At a glance
- Drugs Mirabegron (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 25 Feb 2016 New trial record